GB796524A
(en)
|
1956-03-21 |
1958-06-11 |
Hickson & Welch Ltd |
Improvements in or relating to optical whitening agents
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
HU204253B
(en)
|
1982-11-22 |
1991-12-30 |
Sandoz Ag |
Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
|
US4828991A
(en)
|
1984-01-31 |
1989-05-09 |
Akzo N.V. |
Tumor specific monoclonal antibodies
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
CA1283827C
(en)
|
1986-12-18 |
1991-05-07 |
Giorgio Cirelli |
Appliance for injection of liquid formulations
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
US4885314A
(en)
|
1987-06-29 |
1989-12-05 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
US4782084A
(en)
|
1987-06-29 |
1988-11-01 |
Merck & Co., Inc. |
HMG-COA reductase inhibitors
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5420245A
(en)
|
1990-04-18 |
1995-05-30 |
Board Of Regents, The University Of Texas |
Tetrapeptide-based inhibitors of farnesyl transferase
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
EP0604181A1
(en)
|
1992-12-21 |
1994-06-29 |
Eli Lilly And Company |
Antitumor compositions and method of treatment
|
WO1994019357A1
(en)
|
1993-02-23 |
1994-09-01 |
Merrell Dow Pharmaceuticals Inc. |
Farnesyl:protein transferase inhibitors as anticancer agents
|
CA2118985A1
(en)
|
1993-04-02 |
1994-10-03 |
Dinesh V. Patel |
Heterocyclic inhibitors of farnesyl protein transferase
|
AU6909194A
(en)
|
1993-05-14 |
1994-12-12 |
Board Of Regents, The University Of Texas System |
Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole
|
US5602098A
(en)
|
1993-05-18 |
1997-02-11 |
University Of Pittsburgh |
Inhibition of farnesyltransferase
|
EP0670314A4
(en)
|
1993-09-22 |
1996-04-10 |
Kyowa Hakko Kogyo Kk |
FARNESYL-TRANSFERASE INHIBITOR.
|
HUT76057A
(en)
|
1993-10-15 |
1997-06-30 |
Schering Corp |
Tricyclic sulfonamide compounds, pharmaceutical compositions containing them, which are useful for inhibition of g-protein function and for treatment of proliferative diseases and process for producing them
|
US5719148A
(en)
|
1993-10-15 |
1998-02-17 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
US5721236A
(en)
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5661152A
(en)
|
1993-10-15 |
1997-08-26 |
Schering Corporation |
Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
IL111235A
(en)
|
1993-10-15 |
2001-03-19 |
Schering Plough Corp |
Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
|
JP2875393B2
(ja)
|
1993-10-15 |
1999-03-31 |
シェーリング コーポレイション |
G−タンパク質機能の阻害および増殖性疾患の治療に有用な三環式カルバメート化合物
|
DE69427127T2
(de)
|
1993-10-25 |
2001-10-04 |
Parke Davis & Co |
Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase
|
ATE177420T1
(de)
|
1993-11-04 |
1999-03-15 |
Abbott Lab |
Cyclobutan-derivate als inhibitoren der squalen- synthetase und der protein-farnesyltransferase
|
US5783593A
(en)
|
1993-11-04 |
1998-07-21 |
Abbott Laboratories |
Inhibitors of squalene synthetase and protein farnesyltransferase
|
HUT75308A
(en)
|
1993-11-05 |
1997-05-28 |
Warner Lambert Co |
Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
|
US5484799A
(en)
|
1993-12-09 |
1996-01-16 |
Abbott Laboratories |
Antifungal dorrigocin derivatives
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
WO1995024612A1
(de)
|
1994-03-07 |
1995-09-14 |
International Business Machines Corporation |
Verfahren und vorrichtung zur schnellen interpolation von zwischenwerten aus periodischen phasenverschobenen signalen und zur erkennung von defekten in einem drehkörper
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
HUT77406A
(hu)
|
1994-03-15 |
1998-04-28 |
Eisai Co., Ltd., |
1-(4-Amino-5-tio-pent-2-en)-il oldalláncot tartalmazó peptidomimetikumok és az ezeket tartalmazó gyógyszerkészítmények
|
US6312699B1
(en)
|
1994-03-28 |
2001-11-06 |
Uab Research Foundation |
Ligands added to adenovirus fiber
|
HUT72440A
(en)
|
1994-03-31 |
1996-04-29 |
Bristol Myers Squibb Co |
Imidazole-containing inhibitors of farnesyl protein transferase and pharmaceutical compositions containing them
|
US5523430A
(en)
|
1994-04-14 |
1996-06-04 |
Bristol-Myers Squibb Company |
Protein farnesyl transferase inhibitors
|
US5510510A
(en)
|
1994-05-10 |
1996-04-23 |
Bristol-Meyers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US5563255A
(en)
|
1994-05-31 |
1996-10-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
CA2192389A1
(fr)
|
1994-06-10 |
1995-12-21 |
Bernard Baudoin |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
US5571792A
(en)
|
1994-06-30 |
1996-11-05 |
Warner-Lambert Company |
Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
|
WO1996005529A1
(en)
|
1994-08-09 |
1996-02-22 |
Micron Optics, Inc. |
Temperature compensated fiber fabry-perot filters
|
AU3192395A
(en)
|
1994-08-11 |
1996-03-07 |
Banyu Pharmaceutical Co., Ltd. |
Substituted amide derivative
|
CA2155448A1
(en)
|
1994-08-11 |
1996-02-12 |
Katerina Leftheris |
Inhibitors of farnesyl protein transferase
|
EP0805154A1
(en)
|
1994-08-12 |
1997-11-05 |
Banyu Pharmaceutical Co., Ltd. |
N,n-disubstituted amic acid derivative
|
DE4429506B4
(de)
|
1994-08-19 |
2007-09-13 |
Degussa Gmbh |
Verfahren zur Extraktion natürlicher Carotinoid-Farbstoffe
|
DE4429653C2
(de)
|
1994-08-20 |
1997-04-03 |
Anton Dr More |
Konverter und Verfahren zum Frischen von Metallschmelzen insbesondere von Roheisen zu Stahl
|
DE69507284T2
(de)
|
1994-11-22 |
1999-07-01 |
Philips Electronics Nv |
Halbleiter mit einem träger auf dem ein substrat mit einem halbleiter-element mittels einer klebeschicht und ein leiterbahn-muster befestigt sind
|
WO1996017861A1
(en)
|
1994-12-09 |
1996-06-13 |
Warner-Lambert Company |
Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
|
AU703440B2
(en)
|
1995-01-09 |
1999-03-25 |
Magla International Ltd. |
Wear resistant image printing on latex surfaces
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
WO1996021456A1
(en)
|
1995-01-12 |
1996-07-18 |
University Of Pittsburgh |
Inhibitors of prenyl transferases
|
FR2729390A1
(fr)
|
1995-01-18 |
1996-07-19 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
FR2730491B1
(fr)
|
1995-02-09 |
1997-03-14 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
FR2730492B1
(fr)
|
1995-02-09 |
1997-03-14 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
US5684013A
(en)
|
1995-03-24 |
1997-11-04 |
Schering Corporation |
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
US5700806A
(en)
|
1995-03-24 |
1997-12-23 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
IL117798A
(en)
|
1995-04-07 |
2001-11-25 |
Schering Plough Corp |
Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
|
US5712280A
(en)
|
1995-04-07 |
1998-01-27 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
MX9707561A
(es)
|
1995-04-07 |
1997-12-31 |
Schering Corp |
Compuestos de carbonil piperazinilo y piperidinilo.
|
US5891872A
(en)
|
1995-04-07 |
1999-04-06 |
Schering Corporation |
Tricyclic compounds
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
IL118101A0
(en)
|
1995-05-03 |
1996-09-12 |
Abbott Lab |
Inhibitors of farnesyltransferase
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
AU6034296A
(en)
|
1995-06-16 |
1997-01-15 |
Warner-Lambert Company |
Tricyclic inhibitors of protein farnesyltransferase
|
FR2736641B1
(fr)
|
1995-07-10 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
AT402617B
(de)
|
1995-07-11 |
1997-07-25 |
Datacon Schweitzer & Zeindl Gm |
Anlage zum automatisierten, hermetischen anlage zum automatisierten, hermetischen verschliessen von gehäusen verschliessen von gehäusen
|
FR2736638B1
(fr)
|
1995-07-12 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
CH690163A5
(fr)
|
1995-07-28 |
2000-05-31 |
Symphar Sa |
Dérivés gem-diphosphonates substitués utiles en tant qu'agents anti-cancers.
|
DE69627195T2
(de)
*
|
1995-11-01 |
2004-01-29 |
Novartis Ag |
Purinderivate und verfahren zu ihrer herstellung
|
ES2196186T3
(es)
|
1995-11-06 |
2003-12-16 |
Univ Pittsburgh |
Inhibidores de protein-isoprenil-transferasas.
|
AU704139B2
(en)
|
1995-11-22 |
1999-04-15 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
DE69620445T2
(de)
|
1995-12-08 |
2002-12-12 |
Janssen Pharmaceutica Nv |
(imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
|
SK86198A3
(en)
|
1995-12-22 |
1999-02-11 |
Schering Corp |
Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
AU1529997A
(en)
|
1996-01-16 |
1997-08-11 |
Warner-Lambert Company |
Substituted histidine inhibitors of protein farnesyltransferase
|
US6673927B2
(en)
|
1996-02-16 |
2004-01-06 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Farnesyl transferase inhibitors
|
WO1997038665A2
(en)
|
1996-04-03 |
1997-10-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
CZ376498A3
(cs)
|
1996-05-22 |
1999-02-17 |
Warner-Lambert Company |
Inhibitory proteinové farnesyl fransferázy
|
EP0918771A4
(en)
|
1996-07-15 |
2001-02-07 |
Bristol Myers Squibb Co |
THIADIOXOBENZODIAZEPINES FOR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS
|
US5866702A
(en)
*
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
JP2001507699A
(ja)
|
1996-12-30 |
2001-06-12 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル蛋白トランスフェラーゼ阻害薬
|
EP1003374A1
(en)
|
1996-12-30 |
2000-05-31 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
US6262096B1
(en)
|
1997-11-12 |
2001-07-17 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
US6040321A
(en)
|
1997-11-12 |
2000-03-21 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
US6214852B1
(en)
|
1998-10-21 |
2001-04-10 |
Bristol-Myers Squibb Company |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
IL144578A0
(en)
|
1999-01-29 |
2002-05-23 |
Imclone Systems Inc |
Antibodies specific to kdr and uses thereof
|
GB9903762D0
(en)
*
|
1999-02-18 |
1999-04-14 |
Novartis Ag |
Organic compounds
|
GB9904387D0
(en)
|
1999-02-25 |
1999-04-21 |
Pharmacia & Upjohn Spa |
Antitumour synergistic composition
|
AU4972900A
(en)
|
1999-04-08 |
2000-11-14 |
Arch Development Corporation |
Use of anti-vegf antibody to enhance radiation in cancer therapy
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
PL355639A1
(en)
|
1999-09-10 |
2004-05-04 |
Merck & Co, Inc. |
Tyrosine kinase inhibitors
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
NZ517758A
(en)
|
1999-09-17 |
2004-06-25 |
Abbott Gmbh & Co |
Pyrazolopyrimidines useful as therapeutic agents
|
WO2001021596A1
(en)
|
1999-09-21 |
2001-03-29 |
Astrazeneca Ab |
Quinazoline derivatives and their use as pharmaceuticals
|
MY125768A
(en)
|
1999-12-15 |
2006-08-30 |
Bristol Myers Squibb Co |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
TWI284639B
(en)
|
2000-01-24 |
2007-08-01 |
Shionogi & Co |
A compound having thrombopoietin receptor agonistic effect
|
MXPA03001169A
(es)
|
2000-08-10 |
2003-06-30 |
Pharmacia Italia Spa |
Biciclo-pirazoles activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que comprenden los mismos.
|
ES2324763T3
(es)
*
|
2000-10-31 |
2009-08-14 |
Aventis Pharmaceuticals Inc. |
Derivados acilo y sulfonilo de 2-(trans-1,4-diaminociclohexil)-purinas 6,9-disustituidas y su uso como agentes antiproliferativos.
|
US7429599B2
(en)
|
2000-12-06 |
2008-09-30 |
Signal Pharmaceuticals, Llc |
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
|
MXPA03005610A
(es)
|
2000-12-21 |
2003-10-06 |
Vertex Pharma |
Compuestos de pirazol utiles como inhibidores de la proteina cinasa.
|
CA2433018A1
(en)
|
2000-12-21 |
2002-06-27 |
Joel C. Barrish |
Thiazolyl inhibitors of tec family tyrosine kinases
|
FR2818642B1
(fr)
*
|
2000-12-26 |
2005-07-15 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
DE60223790D1
(de)
|
2001-03-29 |
2008-01-10 |
Vertex Pharma |
Hemmer von c-jun-terminal kinase (jnk) und andere protein kinase
|
EP1401469A2
(en)
|
2001-04-09 |
2004-03-31 |
Lorantis Limited |
Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
|
US6881737B2
(en)
|
2001-04-11 |
2005-04-19 |
Amgen Inc. |
Substituted triazinyl acrylamide derivatives and methods of use
|
JP2002338537A
(ja)
|
2001-05-16 |
2002-11-27 |
Mitsubishi Pharma Corp |
アミド化合物およびその医薬用途
|
FR2825278A1
(fr)
*
|
2001-05-30 |
2002-12-06 |
Sod Conseils Rech Applic |
Produit comprenant du mikanolide, du dihydromikanolide ou un analogue de ceux-ci en association avec un autre agent anti-cancereux pour une utilisation therapeutique dans le traitement du cancer
|
DE60214703T2
(de)
|
2001-06-01 |
2007-09-13 |
Vertex Pharmaceuticals Inc., Cambridge |
Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
|
DE60232510D1
(de)
|
2001-06-15 |
2009-07-16 |
Vertex Pharma |
5-(2-aminopyrimidin-4-yl)benzisoxazole als proteinkinasehemmer
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
WO2003026666A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors
|
WO2003051847A1
(en)
|
2001-12-19 |
2003-06-26 |
Smithkline Beecham P.L.C. |
(1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
WO2003095448A1
(en)
|
2002-05-06 |
2003-11-20 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
CA2486101C
(en)
|
2002-05-17 |
2009-07-07 |
Pharmacia Italia S.P.A. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
US7041692B2
(en)
|
2002-06-19 |
2006-05-09 |
Bristol-Myers Squibb Company |
Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus
|
TW200401638A
(en)
|
2002-06-20 |
2004-02-01 |
Bristol Myers Squibb Co |
Heterocyclic inhibitors of kinases
|
US7361665B2
(en)
|
2002-07-09 |
2008-04-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
|
TWI329112B
(en)
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
EP1537116B1
(en)
*
|
2002-09-04 |
2010-06-02 |
Schering Corporation |
Pyrazolopyrimidines suitable for the treatment of cancer diseases
|
US7196078B2
(en)
*
|
2002-09-04 |
2007-03-27 |
Schering Corpoartion |
Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
US7119200B2
(en)
*
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
US7205308B2
(en)
*
|
2002-09-04 |
2007-04-17 |
Schering Corporation |
Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
|
CN1880317B
(zh)
*
|
2002-09-04 |
2012-10-10 |
先灵公司 |
作为细胞周期蛋白依赖性激酶抑制剂的吡唑并嘧啶
|
ATE362474T1
(de)
*
|
2002-09-04 |
2007-06-15 |
Schering Corp |
Pyrazolo(1,5-a)pyrimidine als hemmstoffe cyclin- abhängiger kinasen
|
MY136840A
(en)
*
|
2002-09-19 |
2008-11-28 |
Schering Corp |
Pyrazolopyridines as cyclin dependent kinase inhibitors
|
US20050250837A1
(en)
|
2002-10-18 |
2005-11-10 |
D Mello Santosh R |
Use of C-Raf inhibitors for the treatment of neurodegenerative diseases
|
WO2004039796A1
(de)
|
2002-10-28 |
2004-05-13 |
Bayer Healthcare Ag |
Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
|
UA81790C2
(uk)
|
2002-12-19 |
2008-02-11 |
Фармация Италия С.П.А. |
Заміщені піролопіразольні похідні як інгібітори кінази
|
FR2850022B1
(fr)
|
2003-01-22 |
2006-09-08 |
Centre Nat Rech Scient |
Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications
|
US7169771B2
(en)
|
2003-02-06 |
2007-01-30 |
Bristol-Myers Squibb Company |
Thiazolyl-based compounds useful as kinase inhibitors
|
EP1597256A1
(en)
|
2003-02-21 |
2005-11-23 |
Pfizer Inc. |
N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
|
GB0304665D0
(en)
*
|
2003-02-28 |
2003-04-02 |
Teijin Ltd |
Compounds
|
CA2516824A1
(en)
|
2003-02-28 |
2004-09-10 |
Teijin Pharma Limited |
Pyrazolo[1,5-a]pyrimidine derivatives
|
GB0305142D0
(en)
|
2003-03-06 |
2003-04-09 |
Eisai London Res Lab Ltd |
Synthesis
|
GB0305559D0
(en)
*
|
2003-03-11 |
2003-04-16 |
Teijin Ltd |
Compounds
|
US7276502B2
(en)
|
2003-03-25 |
2007-10-02 |
Vertex Pharmaceuticals Incorporated |
Thiazoles useful as inhibitors of protein kinases
|
WO2004087707A1
(en)
*
|
2003-03-31 |
2004-10-14 |
Vernalis (Cambridge) Limited |
Pyrazolopyrimidine compounds and their use in medicine
|
US20050008640A1
(en)
|
2003-04-23 |
2005-01-13 |
Wendy Waegell |
Method of treating transplant rejection
|
SI1638941T1
(sl)
|
2003-05-22 |
2010-11-30 |
Abbott Lab |
Inhibitorji indazol benzizoksazol in benzizotiazol kinaze
|
SE0301906D0
(sv)
|
2003-06-26 |
2003-06-26 |
Astrazeneca Ab |
New compounds
|
CA2532965C
(en)
|
2003-07-22 |
2013-05-14 |
Astex Therapeutics Limited |
3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
US7442698B2
(en)
|
2003-07-24 |
2008-10-28 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
EP1651648A4
(en)
|
2003-07-29 |
2009-09-02 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
|
JP4607879B2
(ja)
|
2003-08-15 |
2011-01-05 |
ノバルティス アーゲー |
新生物疾患、炎症および免疫障害の処置に有用な2,4−ピリミジンジアミン
|
WO2005037845A1
(en)
|
2003-10-17 |
2005-04-28 |
Rigel Pharmaceuticals, Inc. |
Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors
|
WO2005037797A1
(en)
|
2003-10-21 |
2005-04-28 |
Pharmacia Corporation |
Substituted pyrazole urea compounds for the treatment of inflammation
|
CA2542909C
(en)
|
2003-10-23 |
2012-07-10 |
Ab Science |
2-aminoaryloxazole compounds as tyrosine kinase inhibitors
|
DE10357510A1
(de)
|
2003-12-09 |
2005-07-07 |
Bayer Healthcare Ag |
Heteroarylsubstituierte Benzole
|
BRPI0418031A
(pt)
|
2003-12-22 |
2007-04-17 |
Gilead Sciences Inc |
inibidores de quinase fosfonato-substituìdos
|
CN1960995B
(zh)
|
2004-04-02 |
2010-12-08 |
诺瓦提斯公司 |
作为葡糖激酶活化剂、可用于治疗ⅱ型糖尿病的磺酰胺-噻唑并吡啶衍生物
|
DE102004017438A1
(de)
|
2004-04-08 |
2005-11-03 |
Bayer Healthcare Ag |
Hetaryloxy-substituierte Phenylaminopyrimidine
|
US20050228031A1
(en)
|
2004-04-13 |
2005-10-13 |
Bilodeau Mark T |
Tyrosine kinase inhibitors
|
DE102004020570A1
(de)
|
2004-04-27 |
2005-11-24 |
Bayer Healthcare Ag |
Substituierte Phenylaminopyrimidine
|
GB0411791D0
(en)
|
2004-05-26 |
2004-06-30 |
Cyclacel Ltd |
Compounds
|
FR2871158A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
ES2396135T3
(es)
|
2004-06-10 |
2013-02-19 |
Irm Llc |
Compuestos y composiciones como inhibidores de proteínas cinasas
|
DE102004028862A1
(de)
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
CA2577275A1
(en)
|
2004-08-31 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
US20060100226A1
(en)
|
2004-09-10 |
2006-05-11 |
Sikorski James A |
2-Thiopyrimidinones as therapeutic agents
|
AU2005286731A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
|
AU2005293384A1
(en)
|
2004-10-15 |
2006-04-20 |
Astrazeneca Ab |
Quinoxalines as B Raf inhibitors
|
US7632854B2
(en)
|
2004-11-17 |
2009-12-15 |
Pfizer Italia S.R.L. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
AU2005322855B2
(en)
|
2004-12-30 |
2012-09-20 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
JP2008528585A
(ja)
|
2005-01-26 |
2008-07-31 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
タンパク質キナーゼ阻害剤としての化合物および組成物
|
TW200639163A
(en)
|
2005-02-04 |
2006-11-16 |
Genentech Inc |
RAF inhibitor compounds and methods
|
WO2006085685A1
(ja)
|
2005-02-09 |
2006-08-17 |
Takeda Pharmaceutical Company Limited |
ピラゾール化合物
|
NZ561000A
(en)
|
2005-02-28 |
2010-01-29 |
Japan Tobacco Inc |
Novel aminopyridine compound with Syk inhibitory activity
|
FR2884516B1
(fr)
|
2005-04-15 |
2007-06-22 |
Cerep Sa |
Antagonistes npy, preparation et utilisations
|
WO2006124731A2
(en)
|
2005-05-12 |
2006-11-23 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
ATE469151T1
(de)
|
2005-05-16 |
2010-06-15 |
Irm Llc |
Pyrrolopyridinderivate als proteinkinaseinhibitoren
|
BRPI0611863B1
(pt)
|
2005-06-22 |
2021-11-23 |
Plexxikon, Inc |
Composto, bem como composição e kit compreendendo o mesmo, composto intermediário na preparação do mesmo, método para tratamento e uso do mesmo
|
WO2007024680A1
(en)
|
2005-08-22 |
2007-03-01 |
Amgen Inc. |
Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
|
WO2007035428A1
(en)
|
2005-09-15 |
2007-03-29 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
US7799820B2
(en)
|
2005-09-30 |
2010-09-21 |
Banyu Pharmaceutical Co., Ltd. |
2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
GB0520955D0
(en)
|
2005-10-14 |
2005-11-23 |
Cyclacel Ltd |
Compound
|
US8247556B2
(en)
|
2005-10-21 |
2012-08-21 |
Amgen Inc. |
Method for preparing 6-substituted-7-aza-indoles
|
US20070161645A1
(en)
|
2005-11-02 |
2007-07-12 |
Targegen, Inc. |
Thiazole inhibitors targeting resistant kinase mutations
|
ES2435405T3
(es)
|
2005-12-21 |
2013-12-19 |
Pfizer Products Inc. |
Carbonilamino pirrolopirazoles, potentes inhibidores de quinasa
|
WO2007071963A2
(en)
|
2005-12-22 |
2007-06-28 |
Astrazeneca Ab |
Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
|
PL1973545T3
(pl)
|
2005-12-23 |
2013-05-31 |
Ariad Pharma Inc |
Bicykliczne Związki Heteroarylowe
|
WO2007076161A2
(en)
|
2005-12-27 |
2007-07-05 |
Myriad Genetics, Inc |
Compounds with therapeutic activity
|
WO2007086584A1
(ja)
|
2006-01-30 |
2007-08-02 |
Meiji Seika Kaisha, Ltd. |
新規FabKおよびFabI/K阻害剤
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
EP2027127A1
(en)
*
|
2006-05-22 |
2009-02-25 |
Shering Corporation |
Pyrazolo [1, 5-a]pyrimidines as cdk inhibitors
|
EP2029578A1
(en)
|
2006-05-26 |
2009-03-04 |
AstraZeneca AB |
2-carbocycloamino-4-imidaz0lylpyrimidines as agents for the inhbition of cell proliferation
|
PT2526933E
(pt)
|
2006-09-22 |
2015-06-23 |
Pharmacyclics Inc |
Inibidores da tirosina-quinase de bruton
|
ATE514699T1
(de)
|
2006-10-11 |
2011-07-15 |
Nerviano Medical Sciences Srl |
Substituierte pyrrolopyrazolderivate als kinaseinhibitoren
|
WO2008049856A2
(en)
|
2006-10-25 |
2008-05-02 |
Ingenium Pharmaceuticals Gmbh |
Methods of treating pain using cdk inhibitors
|
CA2668286C
(en)
|
2006-11-03 |
2014-09-16 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
KR101152162B1
(ko)
|
2006-12-08 |
2012-07-10 |
에프. 호프만-라 로슈 아게 |
치환된 피리미딘 및 jnk 조절제로서 그의 용도
|
EP2120932B1
(en)
|
2006-12-20 |
2014-07-09 |
Nerviano Medical Sciences S.r.l. |
Indazole derivatives as kinase inhibitors for the treatment of cancer
|
JP5225288B2
(ja)
|
2006-12-20 |
2013-07-03 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼ阻害剤として有用なチアゾリル化合物
|
AU2007336811A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
EA017937B1
(ru)
|
2007-02-07 |
2013-04-30 |
Пфайзер Инк. |
ПРОИЗВОДНЫЕ 3-АМИНОПИРРОЛО[3,4-c]ПИРАЗОЛ-5(1H,4H,6H)-КАРБАЛЬДЕГИДА В КАЧЕСТВЕ ИНГИБИТОРОВ РКС
|
MX2009009786A
(es)
|
2007-03-14 |
2009-09-24 |
Exelixis Inc |
Inhibidores de la via de hedgehog.
|
WO2008124393A1
(en)
|
2007-04-04 |
2008-10-16 |
Irm Llc |
Benzothiazole derivatives and their use as protein kinase inhibitors
|
CN104356136A
(zh)
|
2007-04-12 |
2015-02-18 |
辉瑞大药厂 |
作为蛋白酶c抑制剂的3-酰氨基-吡咯并[3,4-c]吡唑-5(1h,4h,6h)甲醛衍生物
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
CA2689989A1
(en)
|
2007-06-04 |
2008-12-11 |
Avila Therapeutics, Inc. |
Heterocyclic compounds and uses thereof
|
WO2008151304A1
(en)
|
2007-06-05 |
2008-12-11 |
Emory University |
Selective inhibitors for cyclin-dependent kinases
|
WO2008154563A1
(en)
|
2007-06-11 |
2008-12-18 |
Bristol-Myers Squibb Company |
1, 3 - dihydroxy substituted phenylamide glucokinase activators
|
JP5561702B2
(ja)
|
2007-08-02 |
2014-07-30 |
アムジエン・インコーポレーテツド |
Pi3キナーゼ調節剤および使用方法
|
US20090054392A1
(en)
|
2007-08-20 |
2009-02-26 |
Wyeth |
Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
AU2008296479A1
(en)
|
2007-08-28 |
2009-03-12 |
Dana Farber Cancer Institute |
Amino substituted pyrimidine, pyrollopyridine and pyrazolopyrimidine derivatives useful as kinase inhibitors and in treating proliferative disorders and diseases associated with angiogenesis
|
WO2009028655A1
(ja)
|
2007-08-30 |
2009-03-05 |
Takeda Pharmaceutical Company Limited |
複素環化合物およびその用途
|
TW200922564A
(en)
|
2007-09-10 |
2009-06-01 |
Curis Inc |
CDK inhibitors containing a zinc binding moiety
|
WO2009122180A1
(en)
|
2008-04-02 |
2009-10-08 |
Medical Research Council |
Pyrimidine derivatives capable of inhibiting one or more kinases
|
GB0806419D0
(en)
|
2008-04-09 |
2008-05-14 |
Ineos Fluor Holdings Ltd |
Process
|
US20100197688A1
(en)
|
2008-05-29 |
2010-08-05 |
Nantermet Philippe G |
Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
|
TWI490214B
(zh)
|
2008-05-30 |
2015-07-01 |
艾德克 上野股份有限公司 |
苯或噻吩衍生物及該等作為vap-1抑制劑之用途
|
WO2009155017A2
(en)
|
2008-05-30 |
2009-12-23 |
Merck & Co., Inc. |
Novel substituted azabenzoxazoles
|
WO2009152027A1
(en)
|
2008-06-12 |
2009-12-17 |
Merck & Co., Inc. |
5,7-dihydro-6h-pyrrolo[2,3-d]pyrimidin-6-one derivatives for mark inhibition
|
WO2009155527A2
(en)
|
2008-06-19 |
2009-12-23 |
Progenics Pharmaceuticals, Inc. |
Phosphatidylinositol 3 kinase inhibitors
|
US20110178070A1
(en)
|
2008-06-24 |
2011-07-21 |
Takeda Pharmaceutical Company Limited |
PI3K/mTOR INHIBITORS
|
GB0812031D0
(en)
|
2008-07-01 |
2008-08-06 |
7Tm Pharma As |
Thiazole derivatives
|
JP2011530511A
(ja)
|
2008-08-05 |
2011-12-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
治療用化合物
|
EP2350053B1
(en)
|
2008-10-17 |
2013-12-11 |
Whitehead Institute For Biomedical Research |
Modulators of MTOR Complexes
|
CN101723936B
(zh)
|
2008-10-27 |
2014-01-15 |
上海睿星基因技术有限公司 |
激酶抑制剂及其在药学中的用途
|
CA2755935A1
(en)
|
2009-02-12 |
2010-08-19 |
Astellas Pharma Inc. |
Hetero ring derivative
|
TW201103943A
(en)
|
2009-04-27 |
2011-02-01 |
Shionogi & Co |
Urea derivative having pi3k inhibitory activity
|
EP2440559B1
(en)
|
2009-05-05 |
2018-01-10 |
Dana-Farber Cancer Institute, Inc. |
Egfr inhibitors and methods of treating disorders
|
WO2010144423A1
(en)
|
2009-06-09 |
2010-12-16 |
Abraxis Bioscience, Llc |
Styryl-triazine derivatives and their therapeutical applications
|
JP6073677B2
(ja)
|
2009-06-12 |
2017-02-01 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
縮合複素環式化合物およびそれらの使用
|
FR2948367A1
(fr)
|
2009-07-24 |
2011-01-28 |
Centre Nat Rech Scient |
Derives d'acyl-guanidines modulateurs de la voie de signalisation des proteines hedgehog
|
EP2488526B1
(en)
|
2009-10-14 |
2013-07-24 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis c
|
US20110207736A1
(en)
*
|
2009-12-23 |
2011-08-25 |
Gatekeeper Pharmaceuticals, Inc. |
Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
CA2791613A1
(en)
|
2010-03-16 |
2011-09-22 |
Dana-Farber Cancer Institute, Inc. |
Indazole compounds and their uses
|
CN104311562B
(zh)
|
2010-05-14 |
2017-07-04 |
达那-法伯癌症研究所 |
用于治疗瘤形成、炎性疾病和其他失调的组合物和方法
|
US8546443B2
(en)
|
2010-12-21 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Benzylic oxindole pyrimidines
|
WO2012090219A2
(en)
|
2010-12-31 |
2012-07-05 |
Jubilant Biosys Ltd. |
Thiazole compounds useful as acetyl-coa carboxylase (acc) inhibitors
|
AU2012288892B2
(en)
|
2011-07-28 |
2016-04-21 |
Cellzome Limited |
Heterocyclyl pyrimidine analogues as JAK inhibitors
|
US20150017156A1
(en)
|
2011-09-16 |
2015-01-15 |
The Ohio State University |
Esx-mediated transcription modulators and related methods
|
CN103814030A
(zh)
*
|
2011-09-22 |
2014-05-21 |
辉瑞大药厂 |
吡咯并嘧啶及嘌呤衍生物
|
AU2012340200B2
(en)
|
2011-11-17 |
2017-10-12 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-Jun-N-Terminal Kinase (JNK)
|
JP6353788B2
(ja)
*
|
2012-01-13 |
2018-07-04 |
エイシア バイオサイエンシーズ インコーポレイテッド |
抗がん剤としての複素環式化合物およびその使用
|
GB201204384D0
(en)
|
2012-03-13 |
2012-04-25 |
Univ Dundee |
Anti-flammatory agents
|
US9879003B2
(en)
|
2012-04-11 |
2018-01-30 |
Dana-Farber Cancer Institute, Inc. |
Host targeted inhibitors of dengue virus and other viruses
|
EP2870261B1
(en)
|
2012-07-09 |
2017-12-06 |
Novartis AG |
Biomarkers associated with cdk inhibitors
|
WO2014015523A1
(en)
*
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
WO2014063068A1
(en)
|
2012-10-18 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
CN103319483B
(zh)
|
2012-10-19 |
2016-08-03 |
药源药物化学(上海)有限公司 |
一种利拉列汀重要中间体的制备方法
|
WO2014063061A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
WO2014063054A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
|
WO2014149164A1
(en)
*
|
2013-03-15 |
2014-09-25 |
Celgene Avilomics Research, Inc. |
Mk2 inhibitors and uses thereof
|
SG11201507615SA
(en)
|
2013-03-20 |
2015-10-29 |
Bayer Pharma AG |
3-acetylamino-1-(phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino)benzene derivatives for the treatment of hyperproliferative disorders
|
US9938279B2
(en)
*
|
2013-04-09 |
2018-04-10 |
Energenesis Biomedical Co., Ltd |
Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)
|
CN112592334B
(zh)
*
|
2013-07-11 |
2023-10-27 |
艾森医药公司 |
嘧啶衍生物作为激酶抑制剂
|
WO2015013635A2
(en)
|
2013-07-25 |
2015-01-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
US10273224B2
(en)
|
2013-08-22 |
2019-04-30 |
Jubilant Biosys Limited |
Substituted pyrimidine compounds, compositions and medicinal applications thereof
|
JP6491202B2
(ja)
|
2013-10-18 |
2019-03-27 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
サイクリン依存性キナーゼ7(cdk7)の多環阻害剤
|
ES2676734T3
(es)
|
2013-10-18 |
2018-07-24 |
Syros Pharmaceuticals, Inc. |
Compuestos heteroatómicos útiles para el tratamiento de enfermedades proliferativas
|
EP3099677A4
(en)
|
2014-01-31 |
2017-07-26 |
Dana-Farber Cancer Institute, Inc. |
Diaminopyrimidine benzenesulfone derivatives and uses thereof
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
CN105940005A
(zh)
|
2014-01-31 |
2016-09-14 |
达纳-法伯癌症研究所股份有限公司 |
二氮杂环庚烷衍生物及其用途
|
JP2017512186A
(ja)
|
2014-01-31 |
2017-05-18 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
ジヒドロプテリジノン誘導体およびその使用
|
PT3126352T
(pt)
|
2014-04-04 |
2018-12-27 |
Syros Pharmaceuticals Inc |
Inibidores da quinase dependente de ciclina 7 (cdk7)
|
US10336760B2
(en)
|
2014-04-05 |
2019-07-02 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
WO2015164604A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
CN104829610B
(zh)
|
2014-06-20 |
2017-03-15 |
中国科学院合肥物质科学研究院 |
一种新型布鲁顿酪氨酸激酶抑制剂
|
DK3172213T3
(da)
|
2014-07-21 |
2021-12-13 |
Dana Farber Cancer Inst Inc |
Makrocykliske kinasehæmmere og anvendelser deraf
|
EP3171874B1
(en)
|
2014-07-21 |
2020-11-18 |
Dana-Farber Cancer Institute, Inc. |
Imidazolyl kinase inhibitors and uses thereof
|
EP3536323A1
(en)
|
2014-08-08 |
2019-09-11 |
Dana Farber Cancer Institute, Inc. |
Uses of salt-inducible kinase (sik) inhibitors
|
US10308648B2
(en)
|
2014-10-16 |
2019-06-04 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
KR102575327B1
(ko)
|
2014-10-31 |
2023-09-07 |
유비이 가부시키가이샤 |
치환 디히드로피롤로피라졸 화합물
|
EP3236959A4
(en)
|
2014-12-23 |
2018-04-25 |
Dana Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
ES2899196T3
(es)
*
|
2015-03-09 |
2022-03-10 |
Aurigene Discovery Tech Ltd |
Derivados de pirazolo[1,5-a][1,3,5]triazina y de pirazolo[1,5-a]pirimidina como inhibidores de CDK
|
CA2978518C
(en)
|
2015-03-27 |
2023-11-21 |
Nathanael S. Gray |
Inhibitors of cyclin-dependent kinases
|
AU2016276963C1
(en)
|
2015-06-12 |
2021-08-05 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
ES2761885T3
(es)
|
2015-08-28 |
2020-05-21 |
Novartis Ag |
Combinaciones farmacéuticas que comprenden (a) el inhibidor de la cinasa dependiente de ciclina 4/6 (CDK4/6) LEE011 (= ribociclib) y (b) el inhibidor del receptor del factor de crecimiento epidérmico (EGFR) erlotinib, para el tratamiento o la prevención del cáncer
|
CA2996978A1
(en)
|
2015-09-09 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
AU2017363307B2
(en)
|
2016-11-22 |
2021-07-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof
|